dipyridamole has been researched along with Acute Lymphoid Leukemia in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Motoyama, O | 1 |
Kojima, Y | 1 |
Ohara, A | 1 |
Tsukimoto, I | 1 |
Ishikawa, Y | 1 |
Iitaka, K | 1 |
Sotomatsu, M | 1 |
Yugami, S | 1 |
Shitara, T | 1 |
Kuroume, T | 1 |
Takimoto, T | 1 |
Kitoh, T | 1 |
Tanizawa, A | 1 |
Akiyama, Y | 1 |
Kiriyama, Y | 1 |
Kubota, M | 1 |
Mikawa, H | 1 |
3 other studies available for dipyridamole and Acute Lymphoid Leukemia
Article | Year |
---|---|
IgA nephropathy associated with leukemia and lymphoma: report of two cases.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Di | 2008 |
Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells.
Topics: Administration, Oral; Antineoplastic Agents; Bone Marrow; Child; Dipyridamole; Dose-Response Relatio | 1993 |
Characterization of nucleoside transport during leukemic cell differentiation.
Topics: Biological Transport; Cell Differentiation; Cytarabine; Deoxycytidine Kinase; Dipyridamole; Humans; | 1989 |